Applied DNA Sciences Inc (APDN)

[mcsharkey]

Ahhh, our top competitor in metabolism based therapy. These guys chose to target GLUCOSE, we shoot at TYROSINE.

Rafael Holdings Provides Update on Rafael Pharmaceuticals’ Two Phase 3 Trials of CPI-613®[/quote]
Phase 3 Clinical Trial in Metastatic Pancreatic Cancer Did Not Meet its Primary Endpoint of Improved Overall Survival
Independent Data Monitoring Committee Recommended the Phase 3 Clinical Trial in Relapsed or Refractory Acute Myeloid Leukemia Be Stopped Due to Lack of Efficacy

Rafael Holdings to Host Conference Call Today at 8:00 a.m. ET

LINK[/quote]Both of us are still in PANCAN's Precision Promise trial.

Real news on Nov 8th¯\_(?)_/¯ ??

GLTUA